|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response
From the Division of Endocrinology, Diabetes and Metabolism and the General Clinical Research Center and the Diabetes Research and Training Center, Washington University School of Medicine, St. Louis, Missouri
Because absence of the glucagon response to falling plasma glucose concentrations plays a key role in the pathogenesis of iatrogenic hypoglycemia in patients with insulin-deficient diabetes and the mechanism of this defect is unknown, and given evidence in experimental animals that a decrease in intraislet insulin is a signal to increased glucagon secretion, we examined the role of endogenous insulin in the physiological glucagon response to hypoglycemia. We tested the hypothesis that intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic—adrenomedullary, sympathetic neural, and parasympathetic neural—response and a low 
-cell glucose concentration. Twelve healthy young adults were studied on three separate occasions. Insulin was infused in hourly steps in relatively low doses (1.5, 3.0, 4.5, and 6.0 pmol · kg-1 · min-1) from 60 through 300 min on all three occasions. Plasma glucose levels were clamped at euglycemia (
5.0 mmol/l, 90 mg/dl) on one occasion and at hourly steps of 4.7, 4.2, 3.6, and 3.0 mmol/l (85, 75, 65, and 55 mg/dl) from 60 through 300 min on the other two occasions. On one of the latter occasions, the ß-cell secretagogue tolbutamide was infused in a dose of 1.0 g/h from 60 through 300 min. Hypoglycemia with tolbutamide infusion, compared with similar hypoglycemia alone, was associated with higher (P < 0.0001) C-peptide levels (final values of 1.0 ± 0.2 vs. 0.1 ± 0.0 nmol/l), higher (P < 0.0001) rates of insulin secretion (final values of 198 ± 60 vs. 15 ± 4 pmol/min), and higher (P < 0.0001) insulin levels (final values of 325 ± 30 vs. 245 ± 20 pmol/l) as expected. The glucagon response to hypoglycemia was prevented during tolbutamide infusion (P < 0.0001). Glucagon levels were 17 ± 1 pmol/l at baseline on both occasions, 14 ± 1 vs. 15 ± 1 pmol/l, respectively, during the initial hyperinsulinemic euglycemia, and 15 ± 1 vs. 22 ± 2 pmol/l, respectively, during hypoglycemia with and without tolbutamide infusion. Autonomic—adrenomedullary (plasma epinephrine), sympathetic neural (plasma norepinephrine), and parasympathetic neural (plasma pancreatic polypeptide)—responses to hypoglycemia were not reduced during tolbutamide infusion. We conclude that intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response and a low -cell glucose concentration.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Rossetti, F. Porcellati, N. Busciantella Ricci, P. Candeloro, P. Cioli, K. S. Nair, F. Santeusanio, G. B. Bolli, and C. G. Fanelli Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People Diabetes, July 1, 2008; 57(7): 1905 - 1917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Schmid, M. Hallschmid, K. Jauch-Chara, N. Bandorf, J. Born, and B. Schultes Sleep Loss Alters Basal Metabolic Hormone Secretion and Modulates the Dynamic Counterregulatory Response to Hypoglycemia J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3044 - 3051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhou, T. Zhang, E. Oseid, J. Harmon, N. Tonooka, and R. P. Robertson Reversal of Defective Glucagon Responses to Hypoglycemia in Insulin-Dependent Autoimmune Diabetic BB Rats Endocrinology, June 1, 2007; 148(6): 2863 - 2869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. White Jr. The Contribution of Medications to Hypoglycemia Unawareness Diabetes Spectr, April 1, 2007; 20(2): 77 - 80. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains Endocr. Rev., February 1, 2007; 28(1): 84 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Canniff, M. S. Smith, D. B. Lacy, P. E. Williams, and M. C. Moore Glucagon secretion and autonomic signaling during hypoglycemia in late pregnancy Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R788 - R795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Meier, L. L. Kjems, J. D. Veldhuis, P. Lefebvre, and P. C. Butler Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes, April 1, 2006; 55(4): 1051 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Inouye, J. T. Y. Yue, O. Chan, T. Kim, E. M. Akirav, E. Park, M. C. Riddell, E. Burdett, S. G. Matthews, and M. Vranic Effects of Insulin Treatment without and with Recurrent Hypoglycemia on Hypoglycemic Counterregulation and Adrenal Catecholamine-Synthesizing Enzymes in Diabetic Rats Endocrinology, April 1, 2006; 147(4): 1860 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Takahashi, H. Ishihara, A. Tamura, S. Yamaguchi, T. Yamada, D. Takei, H. Katagiri, H. Endou, and Y. Oka Cell type-specific activation of metabolism reveals that {beta}-cell secretion suppresses glucagon release from {alpha}-cells in rat pancreatic islets Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E308 - E316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. N. Zammitt and B. M. Frier Hypoglycemia in Type 2 Diabetes: Pathophysiology, frequency, and effects of different treatment modalities Diabetes Care, December 1, 2005; 28(12): 2948 - 2961. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Cryer Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes Diabetes, December 1, 2005; 54(12): 3592 - 3601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Israelian, N. R. Gosmanov, E. Szoke, M. Schorr, S. Bokhari, P. E. Cryer, J. E. Gerich, and C. Meyer Increasing the Decrement in Insulin Secretion Improves Glucagon Responses to Hypoglycemia in Advanced Type 2 Diabetes Diabetes Care, November 1, 2005; 28(11): 2691 - 2696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. McCrimmon, M. L. Evans, X. Fan, E. C. McNay, O. Chan, Y. Ding, W. Zhu, D. X. Gram, and R. S. Sherwin Activation of ATP-Sensitive K+ Channels in the Ventromedial Hypothalamus Amplifies Counterregulatory Hormone Responses to Hypoglycemia in Normal and Recurrently Hypoglycemic Rats Diabetes, November 1, 2005; 54(11): 3169 - 3174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Rickels, M. H. Schutta, R. Mueller, J. F. Markmann, C. F. Barker, A. Naji, and K. L. Teff Islet Cell Hormonal Responses to Hypoglycemia After Human Islet Transplantation for Type 1 Diabetes Diabetes, November 1, 2005; 54(11): 3205 - 3211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hussain, J. Bryan, H. T. Christesen, K. Brusgaard, and L. Aguilar-Bryan Serum Glucagon Counterregulatory Hormonal Response to Hypoglycemia Is Blunted in Congenital Hyperinsulinism Diabetes, October 1, 2005; 54(10): 2946 - 2951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Shiota, J. V. Rocheleau, M. Shiota, D. W. Piston, and M. A. Magnuson Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E570 - E577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Franklin, J. Gromada, A. Gjinovci, S. Theander, and C. B. Wollheim {beta}-Cell Secretory Products Activate {alpha}-Cell ATP-Dependent Potassium Channels to Inhibit Glucagon Release Diabetes, June 1, 2005; 54(6): 1808 - 1815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Gosmanov, E. Szoke, Z. Israelian, T. Smith, P. E. Cryer, J. E. Gerich, and C. Meyer Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans Diabetes Care, May 1, 2005; 28(5): 1124 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Fisher, J. C. Bruning, S. Lannon, and C. R. Kahn Insulin Signaling in the Central Nervous System Is Critical for the Normal Sympathoadrenal Response to Hypoglycemia Diabetes, May 1, 2005; 54(5): 1447 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gabriely and H. Shamoon Fructose Normalizes Specific Counterregulatory Responses to Hypoglycemia in Patients With Type 1 Diabetes Diabetes, March 1, 2005; 54(3): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Raju and P. E. Cryer Loss of the Decrement in Intraislet Insulin Plausibly Explains Loss of the Glucagon Response to Hypoglycemia in Insulin-Deficient Diabetes: Documentation of the Intraislet Insulin Hypothesis in Humans Diabetes, March 1, 2005; 54(3): 757 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tomky Detection, Prevention, and Treatment of Hypoglycemia in the Hospital Diabetes Spectr, January 1, 2005; 18(1): 39 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Evans, R. J. McCrimmon, D. E. Flanagan, T. Keshavarz, X. Fan, E. C. McNay, R. J. Jacob, and R. S. Sherwin Hypothalamic ATP-sensitive K + Channels Play a Key Role in Sensing Hypoglycemia and Triggering Counterregulatory Epinephrine and Glucagon Responses Diabetes, October 1, 2004; 53(10): 2542 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhou, P. O. T. Tran, S. Yang, T. Zhang, E. LeRoy, E. Oseid, and R. P. Robertson Regulation of {alpha}-Cell Function by the {beta}-Cell During Hypoglycemia in Wistar Rats: the "Switch-off" Hypothesis Diabetes, June 1, 2004; 53(6): 1482 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Hope, P. O. T. Tran, H. Zhou, E. Oseid, E. Leroy, and R. P. Robertson Regulation of {alpha}-Cell Function by the {beta}-Cell in Isolated Human and Rat Islets Deprived of Glucose: the "Switch-off" Hypothesis Diabetes, June 1, 2004; 53(6): 1488 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Cryer Diverse Causes of Hypoglycemia-Associated Autonomic Failure in Diabetes N. Engl. J. Med., May 27, 2004; 350(22): 2272 - 2279. [Full Text] [PDF]
|
|
|
|
|
|
A. Omer, V. F. Duvivier-Kali, W. Aschenbach, V. Tchipashvili, L. J. Goodyear, and G. C. Weir Exercise Induces Hypoglycemia in Rats With Islet Transplantation Diabetes, February 1, 2004; 53(2): 360 - 365. [Abstract] [Full Text]
|
|
|
|
|
|
R. P. Robertson, D. E.R. Sutherland, E. R. Seaquist, and K. J. Lanz Glucagon, Catecholamine, and Symptom Responses to Hypoglycemia in Living Donors of Pancreas Segments Diabetes, July 1, 2003; 52(7): 1689 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Cryer, S. N. Davis, and H. Shamoon Hypoglycemia in Diabetes Diabetes Care, June 1, 2003; 26(6): 1902 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. McCrimmon, M. L. Evans, R. J. Jacob, X. Fan, Y. Zhu, G. I. Shulman, and R. S. Sherwin AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1076 - E1083. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |